In Vitro and in Vivo antitumor activity and the mechanism of siphonodictyal B in human colon cancer cellsSonoko Chikamatsu, Chikashi Ishioka, Ken Saijo et al.|Cancer Medicine|2019Cited by 13
Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimensKen Saijo, Chikashi Ishioka, Hiroo Imai et al.|Frontiers in Oncology|2023Cited by 10
Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cellsYoshifumi Kawamura, Chikashi Ishioka, Ken Saijo et al.|Cancer Science|2021Cited by 9
Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective StudyHiroo Imai, Chikashi Ishioka, Hidekazu Shirota et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2022Cited by 9
Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective AnalysisAkira Okita, Chikashi Ishioka, Hiroo Imai et al.|The Tohoku Journal of Experimental Medicine|2018Cited by 7